Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Billions.
The item "Accounts-Payable" stands at 438.98 Billion Japanese Yens as of 09/30/2025.
As of the end of Takeda Pharmaceutical Co. Ltd.'s second quarter, the item "Accounts Payable" stands at 438.98 Billion JPY. This represents an increase of 4.20 percent compared to it's value at the end of it's first quarter .
Regarding the One-Year-Change of the series, the current value constitutes an increase of 6.21 percent compared to the value the year prior.
The 1 year change in percent is 6.21.
The 3 year change in percent is 12.96.
The 5 year change in percent is 60.93.
The 10 year change in percent is 178.44.
| Logo | Name | Market Cap (USD) |
|---|---|---|
![]() | Eli Lilly and Company - Accounts Payable | 905,699,262,464.00 |
![]() | Johnson & Johnson - Accounts Payable | 486,508,953,600.00 |
![]() | AbbVie Inc - Accounts Payable | 399,570,305,024.00 |
![]() | Roche Holding AG - Accounts Payable | 317,433,206,677.55 |
![]() | AstraZeneca PLC - Accounts Payable | 280,205,508,085.11 |